Skip to main content

Advertisement

Log in

Recent Advances in Long-Term Management of Asthma

  • Review Article
  • Published:
Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Asthma is one of the most common chronic diseases of childhood with significant morbidity. Management of asthma has evolved from inhaled corticosteroids to personalized therapy in recent years. This article summarizes the recent advances in the management of asthma. The severity of asthma is assessed retrospectively by the level of treatment required to control asthma symptoms.

Recently, there has been an emphasis on not to use short-acting beta-2 agonist (SABA) alone, even for intermittent or mild asthma. Single maintenance and reliever therapy (MART) is increasingly being recommended. Asthma therapy should be personalized based on phenotype (clinical presentations) and endotypes (distinct mechanistic pathways) of asthma and by a continuous cycle of assessment of asthma control and risk assessment, treatment, and reviewing the response in children on treatment. Various add-on therapy like tiotropium and biological monoclonal antibodies have been approved for use in a subset of children with severe asthma. Before considering biologicals, it is vital to have a proper diagnosis, good compliance and inhaler technique, and treatment of comorbidities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Gaillard EA, Kuehni CE, Turner S, et al. European Respiratory Society clinical practice guidelines for the diagnosis of asthma in children aged 5–16 years. Eur Respir J. 2021;58:2004173.

    Article  Google Scholar 

  2. 2021 GINA Main Report. Global Initiative for Asthma - GINA. 2021. Available at: https://ginasthma.org/gina–reports/. Accessed on 7 May 2021.

  3. Martinez FD, Chinchilli VM, Morgan WJ, et al. Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial. Lancet. 2011;377:650–7.

    Article  CAS  Google Scholar 

  4. Sumino K, Bacharier LB, Taylor J, et al. A pragmatic trial of symptom-based inhaled corticosteroid use in African-American children with mild asthma. J Allergy Clin Immunol Pract. 2020;8:176–85.

    Article  Google Scholar 

  5. Expert Panel Working Group of the National Heart, Lung, and Blood Institute (NHLBI) administered and coordinated National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC), Cloutier MM, Baptist AP, et al. 2020 focused updates to the asthma management guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. J Allergy Clin Immunol. 2020;146:1217–70

  6. Sunther M, Marchon K, Gupta A. Tiotropium in the management of paediatric and adolescent asthma: systematic review. Paediatr Respir Rev. 2021;38:58–62.

    PubMed  Google Scholar 

  7. Gupta RS, Fierstein JL, Boon KL, et al. Sensor-based electronic monitoring for asthma: a randomized controlled trial. Pediatrics. 2021;147:e20201330.

  8. Shields MD, ALQahtani F, Rivey MP, McElnay JC. Mobile direct observation of therapy (MDOT) – A rapid systematic review and pilot study in children with asthma. PloS One. 2018;13:e0190031.

  9. Kuruvilla ME, Lee FE-H, Lee GB. Understanding asthma Ppenotypes, endotypes, and mechanisms of disease. Clin Rev Allergy Immunol. 2019;56:219–33.

  10. Petsky HL, Li A, Chang AB. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev. 2017;8:CD005603.

  11. Petsky HL, Kew KM, Chang AB. Exhaled nitric oxide levels to guide treatment for children with asthma. Cochrane Database Syst Rev. 2016;11:CD011439.

  12. Irving S, Fleming L, Ahmad F, et al. Lung clearance index and steroid response in pediatric severe asthma. Pediatr Pulmonol. 2020;55:890–8.

    Article  Google Scholar 

  13. Russo D, Di Filippo P, Attanasi M, Lizzi M, Di Pillo S, Chiarelli F. Biologic therapy and severe asthma in children. Biomedicines. 2021;9:760.

  14. Cevhertas L, Ogulur I, Maurer DJ, et al. Advances and recent developments in asthma in 2020. Allergy. 2020;75:3124–46.

    Article  Google Scholar 

  15. Teach SJ, Gill MA, Togias A, et al. Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. J Allergy Clin Immunol. 2015;136:1476–85.

    Article  CAS  Google Scholar 

  16. Gupta A, Pouliquen I, Austin D, et al. Subcutaneous mepolizumab in children aged 6 to 11 years with severe eosinophilic asthma. Pediatr Pulmonol. 2019;54:1957–67.

    Article  Google Scholar 

  17. Gupta A, Ikeda M, Geng B, et al. Long-term safety and pharmacodynamics of mepolizumab in children with severe asthma with an eosinophilic phenotype. J Allergy Clin Immunol. 2019;144:1336–42.

    Article  CAS  Google Scholar 

  18. Castro M, Corren J, Pavord ID, et al. Dupilumab Efficacy and Safety in Moderate–to–Severe Uncontrolled Asthma. N Engl J Med. 2018;378:2486–96.

    Article  CAS  Google Scholar 

  19. Bacharier LB, Maspero JF, Katelaris CH, et al. Dupilumab efficacy and safety in children with uncontrolled, moderate-to-severe asthma: the phase 3 VOYAGE study. Am J Respir Crit Care Med. 2021;203:A1204.

    Article  Google Scholar 

  20. Abrams EM, Becker AB, Szefler SJ. Current state and future of biologic therapies in the treatment of asthma in children. Pediatr Allergy Immunol Pulmonol. 2018;31:119–31.

    Article  Google Scholar 

  21. Jackson DJ, Bacharier LB, Mauger DT, et al. Quintupling inhaled Ggucocorticoids to prevent childhood asthma exacerbations. N Engl J Med. 2018;378:891–901.

    Article  CAS  Google Scholar 

  22. Thomas M, Bruton A. Breathing exercises for asthma. Breathe. 2014;10:312–22.

    Google Scholar 

  23. Fortescue R, Kew KM, Leung MST. Sublingual immunotherapy for asthma. Cochrane Database Syst Rev. 2020;9:CD011293.

  24. Gupta A, Sjoukes A, Richards D, et al. Relationship serum vitamin D, disease severity, and airway remodeling in children with asthma. Am J Respir Crit Care Med. 2011;184:1342–9.

    Article  CAS  Google Scholar 

  25. Jolliffe DA, Greenberg L, Hooper RL, et al. Vitamin D supplementation to prevent asthma exacerbations: a systematic review and meta-analysis of individual participant data. Lancet Respir Med. 2017;5:881–90.

    Article  CAS  Google Scholar 

  26. Forno E, Bacharier LB, Phipatanakul W, et al. Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: the VDKA randomized clinical trial. JAMA. 2020;324:752–60.

    Article  CAS  Google Scholar 

  27. Jat KR, Goel N, Gupta N, et al. Efficacy of vitamin D supplementation in asthmatic children with vitamin D deficiency: A randomized controlled trial (ESDAC trial). Pediatr Allergy Immunol. 2021;32:479–88.

    Article  CAS  Google Scholar 

  28. Boyle RJ, Pedroletti C, Wickman M, et al; 4A Study Group. Nocturnal temperature controlled laminar airflow for treating atopic asthma: a randomised controlled trial. Thorax. 2012;67:215–21.

  29. Menzies-Gow A, Bafadhel M, Busse WW, et al. An expert consensus framework for asthma remission as a treatment goal. J Allergy Clin Immunol. 2020;145:757–65.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

KRJ: Literature search, manuscript writing, and final approval of manuscript; AG: Critical intellectual input, review of manuscript, and final approval of manuscript. KRJ will act as the guarantor for this paper.

Corresponding author

Correspondence to Kana Ram Jat.

Ethics declarations

Conflict of Interest

None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jat, K.R., Gupta, A. Recent Advances in Long-Term Management of Asthma. Indian J Pediatr 89, 378–386 (2022). https://doi.org/10.1007/s12098-021-04060-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-021-04060-5

Keywords

Navigation